Crestor is not as safe, study shows

Lead author, Richard Karas, analyzed 145 rosuvastatin assocaited adverse reactions during Crestor's first year and found it was much more likely to cause rhabdomyolysis, proteinuria, or kidney failure than other statins. Dr. Karas urges health care providers to consider other statins. AstraZeneca responded that event reports for Crestor were not causally connected to these concerns. The failure to warn on Crestor is significant in these claims against the manufacturer. Also, the aggressive marketing to consumers adds to the liability of AZ in selling these drugs. There are more cases out there than the public is aware of and it seems only a matter of time until AstraZeneca will ahve to pay for the harm caused by this drug.